-
Loading metrics
Open Access
Editorial
The BENEFIT Trial: Where Do We Go from Here?
-
Bernard Pecoul,
Affiliations Drugs for Neglected Diseases Initiative (DNDi), Geneva, Switzerland and Rio de Janeiro, Brazil, The Global Chagas Disease Coalition, Barcelona, Spain
⨯ -
Carolina Batista,
Affiliations Drugs for Neglected Diseases Initiative (DNDi), Geneva, Switzerland and Rio de Janeiro, Brazil, The Global Chagas Disease Coalition, Barcelona, Spain
⨯ -
Eric Stobbaerts,
Affiliations Drugs for Neglected Diseases Initiative (DNDi), Geneva, Switzerland and Rio de Janeiro, Brazil, The Global Chagas Disease Coalition, Barcelona, Spain
⨯ -
Isabella Ribeiro,
Affiliations Drugs for Neglected Diseases Initiative (DNDi), Geneva, Switzerland and Rio de Janeiro, Brazil, The Global Chagas Disease Coalition, Barcelona, Spain
⨯ -
Rafael Vilasanjuan,
Affiliations The Global Chagas Disease Coalition, Barcelona, Spain, IS Global and the Barcelona Centre for International Health Research (CRESIB), Barcelona, Spain
⨯ -
Joaquim Gascon,
Affiliations The Global Chagas Disease Coalition, Barcelona, Spain, IS Global and the Barcelona Centre for International Health Research (CRESIB), Barcelona, Spain
⨯ -
Maria Jesus Pinazo,
Affiliations The Global Chagas Disease Coalition, Barcelona, Spain, IS Global and the Barcelona Centre for International Health Research (CRESIB), Barcelona, Spain
⨯ -
Silvia Moriana,
Affiliations The Global Chagas Disease Coalition, Barcelona, Spain, IS Global and the Barcelona Centre for International Health Research (CRESIB), Barcelona, Spain
⨯ -
Silvia Gold,
Affiliations The Global Chagas Disease Coalition, Barcelona, Spain, Fundacion Mundo Sano, Buenos Aires, Argentina, and Madrid, Spain
⨯ -
Ana Pereiro,
Affiliations The Global Chagas Disease Coalition, Barcelona, Spain, Fundacion Mundo Sano, Buenos Aires, Argentina, and Madrid, Spain
⨯ -
Miriam Navarro,
Affiliations The Global Chagas Disease Coalition, Barcelona, Spain, Fundacion Mundo Sano, Buenos Aires, Argentina, and Madrid, Spain
⨯ -
Faustino Torrico,
Affiliations The Global Chagas Disease Coalition, Barcelona, Spain, Fundacion Ceades and Universidad Mayor de San Simon (UMSS), Cochabamba, Bolivia
⨯ -
Maria Elena Bottazzi,
Affiliations The Global Chagas Disease Coalition, Barcelona, Spain, Sabin Vaccine Institute and Texas Children’s Hospital Center for Vaccine Development, National School of Tropical Medicine at Baylor College of Medicine, Houston, Texas, United States of America
⨯ -
Peter J. Hotez
* E-mail: hotez@bcm.edu
Affiliations The Global Chagas Disease Coalition, Barcelona, Spain, Sabin Vaccine Institute and Texas Children’s Hospital Center for Vaccine Development, National School of Tropical Medicine at Baylor College of Medicine, Houston, Texas, United States of America
⨯
The BENEFIT Trial: Where Do We Go from Here?
- Bernard Pecoul,
- Carolina Batista,
- Eric Stobbaerts,
- Isabella Ribeiro,
- Rafael Vilasanjuan,
- Joaquim Gascon,
- Maria Jesus Pinazo,
- Silvia Moriana,
- Silvia Gold,
- Ana Pereiro
- Published: February 25, 2016
- https://doi.org/10.1371/journal.pntd.0004343